These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21484787)

  • 1. Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents.
    Terpos E; Anargyrou K; Katodritou E; Kastritis E; Papatheodorou A; Christoulas D; Pouli A; Michalis E; Delimpasi S; Gkotzamanidou M; Nikitas N; Koumoustiotis V; Margaritis D; Tsionos K; Stefanoudaki E; Meletis J; Zervas K; Dimopoulos MA;
    Int J Cancer; 2012 Feb; 130(3):735-42. PubMed ID: 21484787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ration of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity.
    Anagnostopoulos A; Eleftherakis-Papaiakovou V; Kastritis E; Tsionos K; Bamias A; Meletis J; Dimopoulos MA; Terpos E
    Br J Haematol; 2007 Jun; 137(6):560-8. PubMed ID: 17451406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced magnetic resonance imaging parameters correlate with advanced revised-ISS and angiopoietin-1/angiopoietin-2 ratio in patients with multiple myeloma.
    Terpos E; Matsaridis D; Koutoulidis V; Zagouri F; Christoulas D; Fontara S; Panourgias E; Gavriatopoulou M; Kastritis E; Dimopoulos MA; Moulopoulos LA
    Ann Hematol; 2017 Oct; 96(10):1707-1714. PubMed ID: 28766001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of angiopoietin-2 in multiple myeloma.
    Pappa CA; Alexandrakis MG; Boula A; Thanasia A; Konsolas I; Alegakis A; Tsirakis G
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1801-5. PubMed ID: 24906877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic cytokines profile in smoldering multiple myeloma: no difference compared to MGUS but altered compared to symptomatic myeloma.
    Gkotzamanidou M; Christoulas D; Souliotis VL; Papatheodorou A; Dimopoulos MA; Terpos E
    Med Sci Monit; 2013 Dec; 19():1188-94. PubMed ID: 24355943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiopoietins as biomarker of disease activity and response to therapy in multiple myeloma.
    Bhaskar A; Gupta R; Vishnubhatla S; Kumar L; Sharma A; Sharma MC; Das P; Thakur SC
    Leuk Lymphoma; 2013 Jul; 54(7):1473-8. PubMed ID: 23113684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib.
    Anargyrou K; Terpos E; Vassilakopoulos TP; Pouli A; Sachanas S; Tzenou T; Masouridis S; Christoulas D; Angelopoulou MK; Dimitriadou EM; Kalpadakis C; Tsionos K; Panayiotidis P; Dimopoulos MA; Pangalis GA; Kyrtsonis MC;
    Haematologica; 2008 Mar; 93(3):451-4. PubMed ID: 18287135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia.
    Schliemann C; Bieker R; Thoennissen N; Gerss J; Liersch R; Kessler T; Büchner T; Berdel WE; Mesters RM
    Leukemia; 2007 Sep; 21(9):1901-6. PubMed ID: 17597808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis.
    Belloni D; Marcatti M; Ponzoni M; Ciceri F; Veschini L; Corti A; Caligaris Cappio F; Ferrarini M; Ferrero E
    Exp Cell Res; 2015 Jan; 330(1):1-12. PubMed ID: 25447443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis.
    Lim HS; Lip GY; Blann AD
    Atherosclerosis; 2005 May; 180(1):113-8. PubMed ID: 15823283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer.
    Hata K; Nakayama K; Fujiwaki R; Katabuchi H; Okamura H; Miyazaki K
    Gynecol Oncol; 2004 Apr; 93(1):215-22. PubMed ID: 15047239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating angiopoietin-2 is elevated in patients with neuroendocrine tumours and correlates with disease burden and prognosis.
    Srirajaskanthan R; Dancey G; Hackshaw A; Luong T; Caplin ME; Meyer T
    Endocr Relat Cancer; 2009 Sep; 16(3):967-76. PubMed ID: 19502452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopoietin-2 levels predict mortality in CKD patients.
    David S; John SG; Jefferies HJ; Sigrist MK; Kümpers P; Kielstein JT; Haller H; McIntyre CW
    Nephrol Dial Transplant; 2012 May; 27(5):1867-72. PubMed ID: 21976741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy.
    Terpos E; Christoulas D; Katodritou E; Bratengeier C; Gkotzamanidou M; Michalis E; Delimpasi S; Pouli A; Meletis J; Kastritis E; Zervas K; Dimopoulos MA
    Int J Cancer; 2012 Sep; 131(6):1466-71. PubMed ID: 22052418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
    Nadar SK; Blann A; Beevers DG; Lip GY
    J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietin-2: a potential novel diagnostic marker in multiple myeloma.
    Joshi S; Khan R; Sharma M; Kumar L; Sharma A
    Clin Biochem; 2011 Jun; 44(8-9):590-5. PubMed ID: 21300047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H; Wierzbowska A; Robak T
    Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of vascular endothelial growth factor and angiopoietin-2 on progression free survival in multiple myeloma.
    Bhaskar A; Gupta R; Sreenivas V; Rani L; Kumar L; Sharma A; Sharma OD; Sharma MC; Thakur SC
    Leuk Res; 2013 Apr; 37(4):410-5. PubMed ID: 23332455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of angiopoietin-2 are associated with the growth of multiple myeloma.
    Pappa CA; Tsirakis G; Samiotakis P; Tsigaridaki M; Alegakis A; Goulidaki N; Alexandrakis MG
    Cancer Invest; 2013 Jul; 31(6):385-9. PubMed ID: 23758184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the angiopoietin-2/angiopoietin-1 and angiopoietin-1/Tie-2 ratios for early sepsis in an emergency department.
    Fang Y; Li C; Shao R; Yu H; Zhang Q; Zhao L
    Crit Care; 2015 Oct; 19():367. PubMed ID: 26463042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.